Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Femoral head decompression relieves SCD hip pain

Publish date:: June 30, 2019

Key clinical point: Core decompression with bone marrow aspirate concentrate (CD+BMAC) produced clinically significant improvements in pain and function in sickle cell patients, versus core decompression (CD) alone.

Major finding: Among the CD+BMAC patients, pain scores declined two points on average, from 6 preoperatively to 4 postoperatively.

Study details: Single-center study of 35 hips in 29 sickle cell disease patients with an average of 3.6 years of follow-up.

Disclosures: Dr. Fornari reported having no financial disclosures.

Citation:

Fornari ED et al. FSCDR 2019, Abstract JSCDH-D-19-00004.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Hematology

Emotions, worse attention linked to pain-related health care use SCD,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Large cohort study: Bevacizumab safe, effective for severe HHT bleeds,

SPK-8011 AAV-mediated Hemophilia A therapy shows stability, durability,

Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders,